ℹ

We use cookies to ensure that the website works as intended and to collect statistics on its use so that we can improve your web site experience.

×
Krilloil.com
Krill Oil Supports

Heart Health

Backed by 8 human clinical studies, krill oil has been shown to improve heart health by influencing blood lipids, reducing inflammation, and supporting vascular function:

  • Triglyceride Reduction: Krill oil significantly lowers triglyceride levels, a key risk factor for heart disease. Studies show that the omega-3s in krill oil reduce triglycerides more effectively due to their phospholipid-bound form, which enhances absorption and bioavailability​​.
  • Cholesterol Management: Krill oil has been shown to increase HDL ("good") cholesterol while reducing LDL ("bad") cholesterol, contributing to improved cardiovascular health​.
  • Inflammation Modulation: Omega-3s from krill oil help reduce inflammatory markers, such as C-reactive protein (CRP), which are linked to cardiovascular disease​.
2022 MOZAFFARIAN

Effectiveness of a Novel Omega-3 Krill Oil Agent in Patients with Severe Hypertriglyceridemia, a Randomized Clinical Trial

Published randomized, double-blind, placebo-controlled

Location: USA, CAN, MEX Time Frame: 26 wks

Population: Subjects with hypertriglyceridemia

Age Range: 18+ Total Subjects: 520
Krill Oil Group: n=372 Dose: 4/g/day of krill oil (885 mg EPS, 345 mg DHA)
Placebo Gourp: n=148 Dose: 4/g/day of krill oil (885 mg EPS, 345 mg DHA)
Key Significant Krill Oil Results vs Placebo:
  • Reduced TG levels by 26% at 12 wks (p=.02) and 33.5% at 26 wks (p=.02) 
  • Increased percentage of subjects to achieve TG levels <500 mgs (p=.02) 
  • Reduced non-HDL at 26 wks (p=,04) 
  • Reduced ApoC3 at 26 wks (p=.03)
  • Increased EPA/DHA at all study visits (p<.05) 

 

See Jounal Article
2018 RUNDBLAD

Effects of krill oil and lean and fatty fish on cardiovascular risk markers: a randomized controlled trial

Published randomized, double-blind, placebo-controlled

Location: Norway Time Frame: 8 wks

Population: Healthy subjects

Age Range: 18-70 Total Subjects: 36
Krill Oil Group: n=12 Dose: 4/g/day of krill oil (885 mg EPS, 345 mg DHA)
Fish Group: n=12 Dose: 3 weekly fish meals (245 g lean/fatty fish)
Placebo Group: n=12 Dose: 4/g/day of krill oil (885 mg EPS, 345 mg DHA)
Key Significant Krill Oil Results vs Placebo:
  • Reduced in fasting glucose levels (p=.01)vs fish and placebo
  • Increased XS-VLDL vs fish and placebo (p=.007)
  • Increased in EPA & DPA vs fish and placebo (p<.05)
See Jounal Article
2016 CICERIO

Lipid-lowering and anti-inflammatory effects of omega 3 ethyl esters and krill oil: a randomized, cross-over, clinical trial

Published randomized, double-blind, placebo-controlled

Location: Italy Time Frame: 16 wks

Population: Subjects with hypertriglyceridemia

Range: 18-70 Total Subjects: 25
Krill Oil Group: n=25 Dose: 1/g/day of krill oil (150 mg EPS, 90mg DHA)
Placebo Gourp: n=25 Dose: 2/g/day of fish oil EE (85% EPA/DHA)
Key Significant Krill Oil Results vs Placebo:
  • Improved HDL-C and apoAI levels vs baseline and Fish oil (p<.05)
  • Improved non HDL cholesterol vs Fish oil (p<.05)
  • More efficaciously improved hs-CRP levels vs placebo (p<.05)
See Jounal Article